S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effect of S-adenosylmethionine therapy in those
patients with non-alcoholic liver disease in the form of steatohepatitis (NASH). This will be
accomplished by development of a database of these patients, all of whom will have biopsy
documented NASH. A placebo controlled trial will then examine the effect of
S-adenosylmethionine over time on clinical outcome in these patients. It is expected that
this agent will slow or halt the progression of this disease.
Phase:
Phase 3
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development